Development of mature BDNF-specific sandwich ELISA

Journal of Neurochemistry

Volumn 134, Issue 1, 2015, Pages 75-85

  Lim, Yoon ^a,b   Zhong, Jin Hua ^a   Zhou, Xin Fu ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

ELISA and cross reactivity; mature BDNF (mBDNF); proBDNF

Indexed keywords

BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; POLYCLONAL ANTIBODY; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ANIMAL TISSUE; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; MOLECULAR CLONING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SHEEP; VALIDATION STUDY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; GENETICS; KNOCKOUT MOUSE; MOUSE; SPRAGUE DAWLEY RAT; STANDARDS; TRENDS;

MUS; OVIS ARIES; RATTUS;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; SHEEP;

EID: 84935897782     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13108     Document Type: Article

References (34)

1. Angelucci F., Spalletta G., di Iulio F., et al,. (2010) Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels. Curr. Alzheimer Res. 7, 15-20.
2. Chen Z. Y., Jing D., Bath K. G., et al,. (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140-143.
3. Cunha A. B., Frey B. N., Andreazza A. C., Goi J. D., Rosa A. R., Goncalves C. A., Santin A., and, Kapczinski F., (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 398, 215-219.
4. Davies A. M., (1994) The role of neurotrophins during successive stages of sensory neuron development. Prog. Growth Factor Res. 5, 263-289.
5. Feinberg M., Sohier D., and, David J. F., (2009) Validation of an alternative method for counting Enterobacteriaceae in foods based on accuracy profile. J. AOAC Int. 92, 527-537.
6. Hashimoto K., (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin. Neurosci. 64, 341-357.
7. Huang E. J., and, Reichardt L. F., (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677-736.
8. Huang T. L., Lee C. T., and, Liu Y. L., (2008) Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J. Psychiatr. Res. 42, 521-525.
9. Karege F., Schwald M., and, Cisse M., (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328, 261-264.
10. Kimura R., Devi L., and, Ohno M., (2010) Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J. Neurochem. 113, 248-261.
11. Klein A. B., Williamson R., Santini M. A., Clemmensen C., Ettrup A., Rios M., Knudsen G. M., and, Aznar S., (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 14, 347-353.
12. Kolbeck R., Bartke I., Eberle W., and, Barde Y. A., (1999) Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J. Neurochem. 72, 1930-1938.
13. Laske C., Stransky E., Leyhe T., et al,. (2007) BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J. Psychiatr. Res. 41, 387-394.
14. Lee R., Kermani P., Teng K. K., and, Hempstead B. L., (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945-1948.
15. Lin P. Y., (2009) State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study. Neurosci. Lett. 466, 139-143.
16. Mowla S. J., Farhadi H. F., Pareek S., Atwal J. K., Morris S. J., Seidah N. G., and, Murphy R. A., (2001) Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276, 12660-12666.
17. Nagappan G., Zaitsev E., Senatorov V. V., Jr, Yang J., Hempstead B. L., and, Lu B., (2009) Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc. Natl Acad. Sci. USA 106, 1267-1272.
18. Nawa H., Carnahan J., and, Gall C., (1995) BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur. J. Neurosci. 7, 1527-1535.
19. Pang P. T., and, Lu B., (2004) Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res. Rev. 3, 407-430.
20. Pang P. T., Teng H. K., Zaitsev E., et al,. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487-491.
21. Sartorius A., Hellweg R., Litzke J., Vogt M., Dormann C., Vollmayr B., Danker-Hopfe H., and, Gass P., (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42, 270-276.
22. Seidah N. G., Benjannet S., Pareek S., Chretien M., and, Murphy R. A., (1996) Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 379, 247-250.
23. Sodersten K., Palsson E., Ishima T., Funa K., Landen M., Hashimoto K., and, Agren H., (2014) Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J. Affect. Disord. 160, 1-9.
24. Sun Y., Lim Y., Li F., Liu S., Lu J. J., Haberberger R., Zhong J. H., and, Zhou X. F., (2012) ProBDNF collapses neurite outgrowth of primary neurons by activating RhoA. PLoS ONE 7, e35883.
25. Teche S. P., Nuernberg G. L., Sordi A. O., de Souza L. H., Remy L., Cereser K. M., and, Rocha N. S., (2013) Measurement methods of BDNF levels in major depression: a qualitative systematic review of clinical trials. Psychiatr. Q. 84, 485-497.
26. Ullrich A., Gray A., Berman C., and, Dull T. J., (1983) Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303, 821-825.
27. Woo N. H., Teng H. K., Siao C. J., Chiaruttini C., Pang P. T., Milner T. A., Hempstead B. L., and, Lu B., (2005) Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 8, 1069-1077.
28. Xiong J., Zhou L., Lim Y., Yang M., Zhu Y. H., Li Z. W., Zhou F. H., Xiao Z. C., and, Zhou X. F., (2013) Mature BDNF promotes the growth of glioma cells in vitro. Oncol. Rep. 30, 2719-2724.
29. Yoshida T., Ishikawa M., Niitsu T., et al,. (2012a) Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS ONE 7, e42676.
30. Yoshida T., Ishikawa M., Masaomi I., and, Hashimoto K., (2012b) Serum levels of mature brain-derived neurotrophic factor (BDNF) and Its precursor proBDNF in healthy subjects. Open Clin. Chem. J. 5, 7-12.
31. Yoshimura R., Nakano Y., Hori H., Ikenouchi A., Ueda N., and, Nakamura J., (2006) Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Hum. Psychopharmacol. 21, 433-438.
32. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., Ueda N., and, Nakamura J., (2007) Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1034-1037.
33. Zhou L., Xiong J., Lim Y., Ruan Y., Huang C., Zhu Y., Zhong J. H., Xiao Z., and, Zhou X. F., (2013) Upregulation of blood proBDNF and its receptors in major depression. J. Affect. Disord. 150, 776-784.
34. Zhu Y. Y., Jing L., Duan T. T., Yuan Q., Cao J., Zhou Q. X., and, Xu L., (2013) Patterned high-frequency stimulation induces a form of long-term depression dependent on GABAA and mACh receptors in the hippocampus. Neuroscience 250, 658-663.